Fri, Mar 6, 2015, 3:31 PM EST - U.S. Markets close in 29 mins.

Recent

% | $
Quotes you view appear here for quick access.

Oncolytics Biotech Inc. Message Board

skeeta_bug 120 posts  |  Last Activity: Feb 27, 2015 10:55 AM Member since: Nov 22, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • skeeta_bug by skeeta_bug Feb 27, 2015 10:55 AM Flag

    Delisting rapidly approaching. Soon these shares will be worthless. The traders have a heyday with these penny stock shell companies. Check every Yahoo stock message board for every company that is non-compliant on the Nasdaq that is near delisting and you will find that board full of the traders. The common trait is that the traders are incapable of making more than one or two sentence post either trashing or pumping the company depending which side of the trade they are on.

    Skeeta Bug expects lots of volatility and wondering when the big fall will occur.

    Not looking for for SNAKE OIL

    Skeeta Bug Likes It.

    Sentiment: Strong Sell

  • Reply to

    Skeeta Bug Likes all this DELISTING TALK,

    by skeeta_bug Feb 24, 2015 12:44 PM
    skeeta_bug skeeta_bug Feb 24, 2015 3:01 PM Flag

    From budgetingthenest: Does the Nasdaq give additional extensions to stay listed? It just keeps going from bad to horrendous for this SNAKE OIL, Skeeta Bug Likes It

    Initial Grace Period

    The Nasdaq does not immediately delist a company for noncompliance. It provides the company with a grace period in which to "cure" -- or eliminate -- the deficiency. The grace period lasts for 180 calendar days after receipt of the deficiency notice. The company's securities remain listed during this time.

    Second Grace Period Optional

    The Nasdaq may grant a 180-day extension of the initial grace period. In such a case, the stock remains listed throughout the the extension. Not all companies qualify for this second grace period....
    THESE COMPANIES MUST HAVE MAINTAINED THE OTHER NON-PRICE LISTING REQUIREMENTS.

    Conditions for Second Grace Period

    Granting of the second extension is not automatic for those that meet the requirements. A noncompliant company must inform the Nasdaq in writing of its intent to cure the deficiency and how it will do so. Companies often announce their intention to perform a reverse stock split in order to return the share price to above $1. A 1-for-2 reverse stock split provides investors with half the number of shares at twice the price. If the Nasdaq believes the company can cure the deficiency during the extension period, it will grant the additional time.

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 2:28 PM Flag

    "Maybe if you posted less incessantly you'd have time to think before you post. (Free advice: stick to googling & pasting.)"

    No, Bailey,please keep doing what your doing, Skeeta Bug gets good laughs and it makes Skeeta Bugs day.

    Do you think Network Capital will buy this SNAKE OIL?

    -Brad Thompson was the CEO of Genescape and then Genscape was bought by Signalgene and Thompson became a director at Signalgene. Signalgene hits bottom and Network Capital buys for $0.071 cents/share for a company that had $5 million cash and $55 million in tax deductibles.

    -Brad Thompson was CEO of Synsorb which of course later hits bottom and Synsorb also eventually retains Network Capital as financial advisors.

    Brad Thompson is CEO of oncy and ..........?


    Amazing how history keeps repeating itself.

    Sentiment: Strong Sell

  • skeeta_bug by skeeta_bug Feb 24, 2015 1:47 PM Flag

    From Investopedia:

    "How Does It Affect You?
    As a shareholder, you should seriously revisit your investment decision in a company that has become delisted; in many cases, it may be better to cut your losses. A firm unable to meet the listing requirements of the exchange upon which it is traded is quite obviously not in a great position. Each case of delisting needs to be looked at on an individual basis. However, being kicked out of an exclusive club such as the NYSE or the Nasdaq is about as disgraceful for a company as it is prestigious for it to be listed in the first place.

    Even if a company continues to operate successfully after being delisted, the main problem with getting booted from the exclusive club is the trust factor. People lose their faith in the stock. When a stock trades on the NYSE or Nasdaq, it has an aura of reliability and accuracy in reporting financial statements. When a company's stock is demoted to the OTCBB or pink sheets, it loses its reputation. Pink sheet and OTCBB stocks lack the stringent regulation requirements that investors come to expect from NYSE and Nasdaq-traded stocks. Investors are willing to pay a premium for shares of trustworthy companies and are (understandably) leery of firms with shady reputations.

    Another problem for delisted stocks is that many institutional investors are restricted from researching and buying them. Investors who already own a stock prior to the delisting may be forced by their investment mandates to liquidate their positions, further depressing the company's share price by increasing the selling supply. This lack of coverage and buying pressure means the stock has an even steeper climb ahead to make it back on to a major exchange. (See, What happens to my shares of a company that just received a delisting notice?)

    such companies to stay listed would result in the maj

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 1:42 PM Flag

    Unforunately for this SNAKE OIL, the EMA COMP meeting isnt until May 11, 2015 and then there is another month for a decision. This SNAKE OIL will already have been delisted 2 months earlier.

    This SNAKE OIL is nothing but a shell company and that is coming to an end, hence the desperation.

    Skeeta Bug sees the OD fluff PR is already fading for CYTX. Just like oncy, this is an opportune time for CYTX shareholders to get out with a little more cash before it fades away.

    Skeeta Bug Likes It. Snake oil fading away into oblivion.

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 1:15 PM Flag

    "VP Clinical Development can be speculatively interpreted as: ONCY will most likely be purchased by BIG PHARMA OR BIG BIOTECH in the NTDF"

    lol, Skeeta Bug Likes It. Skeeta Bug suggests checking out all the other bios on the Nasdaq Non-Compliant list and then check their yahoo boards. On every single Yahoo biotech board that is getting delisted, their are post stating that they are all getting taken over by big pharma. Too funny. Oh maybe this SNAKE OIL is being kept down because someone is accumulating, thats pretty common too on the delisted boards. Or how about many someone knows something and is accumulating?

    Sentiment: Strong Sell

  • Reply to

    Dirt on Delisting

    by skeeta_bug Oct 3, 2014 12:21 PM
    skeeta_bug skeeta_bug Feb 24, 2015 1:05 PM Flag

    "How Does It Affect You?
    As a shareholder, you should seriously revisit your investment decision in a company that has become delisted; in many cases, it may be better to cut your losses. A firm unable to meet the listing requirements of the exchange upon which it is traded is quite obviously not in a great position"

    Skeeta Bug agress 100%, many here should have cut their losses. Good for those who sold on the recent OD fluff PRs. oncy is quite obviously not in a great position is understating the fact, this SNAKE OIL is in a HORRENDOUS position.

    Thoughts?

    Skeeta Bug Likes It

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 12:49 PM Flag

    "goals are directed toward research either basic or clinical, toward a higher managing position in either
    pharma industry or hospitals."

    Skeeta Bug knows things not looking good at head office. Staff wondering what their gonna do. Skeeta Bug wondering if any severance is being offered to employees to stay?

    Skeeta Bug expects others to join the exodus shortly.

    Skeeta Bug Likes it

    Sentiment: Strong Sell

  • Oh yeah baby, all this DELISTING TALK getting Skeeta Bug excited, Skeeta Bug cant sit still. Skeeta Bug likes the comaradirie when everyone agrees that this SNAKE OIL will not meet Nasdaq compliance.

    Now the debate is whether this SNAKE OIL can actually get an extension.

    Not looking good for SNAKE OIL, in fact its looking horrendous.

    Skeeta Bug Likes It

    Sentiment: Strong Sell

  • Reply to

    This is a RARITY: Were all in AGREEMENT Now

    by skeeta_bug Feb 24, 2015 11:47 AM
    skeeta_bug skeeta_bug Feb 24, 2015 12:27 PM Flag

    "You notice the panic Skeeta?"

    Oh Yeah Baby, Skeeta Bug can feel it. First Bailey was posting relentlessly about becoming the std of care in panc, then nonstop about 3 trillion post about OD and that was the game changer. Now that delisting is in sight, desperation is mounting.

    Would we really expect anything else from Bailey?

    Not looking good for SNAKE OIL, in fact its looking horrendous,

    Skeeta Bug Likes It.

    Sentiment: Strong Sell

  • Skeeta Bug has never seen this before, amazing. Everyone is in agreement that this SNAKE OIL will not meet the Nasdaq minimum standards granted by the initial 180 extension for COMPLIANCE. There are a little above 40 days trading left before delisting.

    Now the scammers are trying to say that another 180 extension is automatic.

    Skeeta Bug Likes It.

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 11:10 AM Flag

    "Initial Grace Period

    The Nasdaq does not immediately delist a company for noncompliance. It provides the company with a grace period in which to "cure" -- or eliminate -- the deficiency. The grace period lasts for 180 calendar days after receipt of the deficiency notice. The company's securities remain listed during this time."

    "Conditions for Second Grace Period

    Granting of the second extension is not automatic for those that meet the requirements. A noncompliant company must inform the Nasdaq in writing of its intent to cure the deficiency and how it will do so. Companies often announce their intention to perform a reverse stock split in order to return the share price to above $1. A 1-for-2 reverse stock split provides investors with half the number of shares at twice the price. If the Nasdaq believes the company can cure the deficiency during the extension period, it will grant the additional time."

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 24, 2015 10:48 AM Flag

    Greenmarshcreek, these Orphan Drug Fluff PRs are a delisted companies last hope to cling to life, but you already know that.

    CYTX in desperate straits just like oncy SNAKE OIL to desperately cling above a dollar before delisting. It is common for companies in desperate straits to get any Fluff PR and orphan PRs are one way to go.

    Sentiment: Strong Sell

  • Reply to

    Now only 42 days to DELISTING

    by skeeta_bug Feb 24, 2015 9:45 AM
    skeeta_bug skeeta_bug Feb 24, 2015 10:29 AM Flag

    Two of Thompsons previous companies namely Synsorb and Genescape which became Signalgene both ceased operations with cash in hand. The reason given by Signalgene was the uncertain prospect of raising cash. Good luck for this SNAKE OIL getting cash once its on the OTC.

    Also Thompson and the exec 6 are in line for millions for severance if sold for a pittance. If Skeeta Bug phones Thompson and says hey I will give you 10 bucks for this SNAKE OIL, Thompson collects millions. Skeeta Bug cant wait to see the next Management Information Circular, Skeeta Bug thinks it highly likely that the payments have been increased significantly. If Thompson rides it out, he will get no severance payment when they are broke. Network Capital was involved in both transactions and Skeeta Bug not gonna be surprised if Network Capital becomes involved again.

    One point though is that both companies were bought for their tax pools and Skeeta But unsure but the laws may have changed regarding this.

    So i guess we will have to agree to disagree about this matter for now.

    Skeeta Bug also wondering, you are of the viewpoint of a reverse split, do you still believe that? The time is winding down before delisting and there is the matter of getting the paperwork, votes, vote counting, etc done.

    Sentiment: Strong Sell

  • Delisting is getting closer and closer every day.

    Skeeta Bug also predicted that this SNAKE OIL will cease operations in the 2nd qtr.

    Skeeta Bug knows lots of volatility coming to the downside. Can you imagine when there are say for example only 20 days left to DELISTING and these shares will become worthless.

    Thoughts?

    Skeeta Bug Likes It

    Sentiment: Strong Sell

  • Reply to

    buy all you want at .53 in a few days

    by greenmarshcreek Feb 23, 2015 3:13 PM
    skeeta_bug skeeta_bug Feb 23, 2015 5:02 PM Flag

    "Nah u ain't c n .20.real news thats results will push it past 1.00 in a flash."

    The only Real news coming is DELISTING and CEASING OPERATIONS, the best of the fluff PRs have already been released. Even the EMA OD fluff PR will occur 2 months after delisting.

    Skeeta Bug Likes It.

    Sentiment: Strong Sell

  • Reply to

    buy all you want at .53 in a few days

    by greenmarshcreek Feb 23, 2015 3:13 PM
    skeeta_bug skeeta_bug Feb 23, 2015 4:42 PM Flag

    hi greenmarshcreek, you'll be able to buy all you want at 20 cents or so in about 2-4 weeks. Skeeta Bug expecting a really big drop in the coming weeks as this SNAKE OIL shell company gets closer to delisting.

    Sentiment: Strong Sell

  • Reply to

    Just a little fun fact...

    by dlaskey Feb 23, 2015 1:20 PM
    skeeta_bug skeeta_bug Feb 23, 2015 1:27 PM Flag

    Dlaskey, quit lying

    Skeeta Bug sarcasm.

    Skeeta Bug Likes It. Not looking good for SNAKE OIL

    Sentiment: Strong Sell

  • Not looking good for SNAKE OIL, delisting in the immediate horizon, VP, clinical development looking to leave a sinking ship, expect others to follow.

    Skeeta Bug Likes It.

    Sentiment: Strong Sell

  • skeeta_bug skeeta_bug Feb 23, 2015 1:00 PM Flag

    "involved in clinical trials in thoracic oncology, management of patients from diagnosis to therapy.
    goals are directed toward research either basic or clinical, toward a higher managing position in either
    pharma industry or hospitals."

    Skeeta Bug Likes it. The ship is sinking and it is definitely a wise move to get out now before she goes under.
    Dr. Selvaggio looking for a job in research toward a higher managing position in either pharma or hospitals.

    Skeeta Bug suggests to check out Dr. Selvaggios Linked In page.

    Thoughts?

    Sentiment: Strong Sell

ONCY
0.9311-0.1189(-11.32%)3:30 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.